Article info
PDFExtended report
Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system
- Correspondence to:
Dr Y Tanaka
The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, 1-1 Iseigaoka Yahata-nishi, Kitakyushu 807-8555 Japan;tanaka{at}med.uoeh-u.ac.jp
Citation
Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system
Publication history
- Accepted October 30, 2006
- First published November 15, 2006.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2007 by Annals of the Rheumatic Diseases